Nationwide population based study of infections after transrectal ultrasound guided prostate biopsy

Journal of Urology

Volumn 192, Issue 4, 2014, Pages 1116-1122

  Lundström, Karl Johan ^a   Drevin, Linda ^b   Carlsson, Stefan ^d   Garmo, Hans ^b   Loeb, Stacy ^e   Stattin, Pär ^a   Bill Axelson, Anna ^c  

^a UMEÅ UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

^e NEW YORK UNIVERSITY   (United States)

Author keywords

anti bacterial agents; biopsy; complications; prostate; urinary tract infections

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; HEPARIN; IMMUNOSUPPRESSIVE AGENT; WARFARIN;

AGED; ANTIBIOTIC THERAPY; ANTICOAGULANT THERAPY; ARTICLE; CHARLSON COMORBIDITY INDEX; COMORBIDITY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIABETES MELLITUS; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HUMAN TISSUE; IATROGENIC DISEASE; IMAGE GUIDED BIOPSY; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION RISK; INFECTIOUS COMPLICATION; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRESCRIPTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; SWEDEN; SWEDISH CITIZEN; TRANSRECTAL ULTRASONOGRAPHY; TRANSRECTAL ULTRASOUND GUIDED PROSTATE BIOPSY; TUMOR BIOPSY; URINARY TRACT INFECTION; CAUSE OF DEATH; CLINICAL TRIAL; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE BIOPSY; EPIDEMIOLOGY; FOLLOW UP; MULTICENTER STUDY; PATHOLOGY; PROCEDURES; PROSTATE; PROSTATE TUMOR; RECTUM; REPRODUCIBILITY; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; TRENDS;

AGED; CAUSE OF DEATH; ENDOSCOPIC ULTRASOUND-GUIDED FINE NEEDLE ASPIRATION; ENDOSONOGRAPHY; FOLLOW-UP STUDIES; HUMANS; MALE; PROSTATE; PROSTATIC NEOPLASMS; RECTUM; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; SWEDEN;

EID: 84921952447     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2014.04.098     Document Type: Article

References (20)

1. S. Lindstedt, U. Lindstrom, and E. Ljunggren Single-dose antibiotic prophylaxis in core prostate biopsy: Impact of timing and identification of risk factors Eur Urol 50 2006 832
2. R. Raaijmakers, W.J. Kirkels, and M.J. Roobol Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program Urology 60 2002 826
3. S. Loeb, S. van den Heuvel, and X. Zhu Infectious complications and hospital admissions after prostate biopsy in a European randomized trial Eur Urol 61 2012 1110
4. R.K. Nam, R. Saskin, and Y. Lee Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy J Urol 183 2010 963
5. S. Loeb, H.B. Carter, and S.I. Berndt Complications after prostate biopsy: data from SEER-Medicare J Urol 186 2011 1830
6. G. Aus, G. Ahlgren, and S. Bergdahl Infection after transrectal core biopsies of the prostate - risk factors and antibiotic prophylaxis Br J Urol 77 1996 851
7. J. Adolfsson, H. Garmo, and E. Varenhorst Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005 Scand J Urol Nephrol 41 2007 456
8. M. Van Hemelrijck, A. Wigertz, and F. Sandin Cohort profile: the National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0 Int J Epidemiol 42 2013 956
9. K. Fall, F. Stromberg, and J. Rosell Reliability of death certificates in prostate cancer patients Scand J Urol Nephrol 42 2008 352
10. B. Wettermark, N. Fau-Hammar, and N. Hammar The new Swedish Prescribed Drug Register - opportunities for pharmacoepidemiological research and experience from the first six months Pharmacoepidemiol Drug Saf 16 2007 726
11. P.C. Albertsen, D.F. Moore, and W. Shih Impact of comorbidity on survival among men with localized prostate cancer J Clin Oncol 29 2011 1335
12. J.C. Truzzi, F.M. Almeida, and E.C. Nunes Residual urinary volume and urinary tract infection - when are they linked? J Urol 180 2008 182
13. Z. Abughosh, J. Margolick, and S.L. Goldenberg A prospective randomized trial of povidone-iodine prophylactic cleansing of the rectum prior to transrectal ultrasound-guided prostate biopsy J Urol 189 2012 1326
14. Socialstyrelsen: The National Board of Health and Welfare Statistics in the Areas of Health and Medical Care, 2009. Available at http://192.137.163.40/epcfs/FisFrameSet.asp?FHStart=ja&W=1440&H=900. Accessed December 13, 2013.
15. Dohnhammar U, Edlund C and Edquist P: SwedRes 2011. Available at http://www.folkhalsomyndigheten.se/documents/projektwebbar/barn/swedres-2011.pdf. Accessed January 24, 2014.
16. S.V. Carlsson, E. Holmberg, and S.M. Moss No excess mortality after prostate biopsy: results from the European Randomized Study of Screening for Prostate Cancer BJU Int 107 2011 1912
17. A. Gallina, N. Suardi, and F. Montorsi Mortality at 120 days after prostatic biopsy: a population-based study of 22,175 men Int J Cancer 123 2008 647
18. J.F. Ludvigsson, E. Andersson, and A. Fau-Ekbom External review and validation of the Swedish national inpatient register BMC Public Health 11 2011 450
19. S. Carlsson, O. Bratt, and P. Stattin Current routines for transrectal ultrasound-guided prostate biopsy: a web-based survey by the Swedish Urology Network Scand J Urol Nephrol 46 2012 405
20. A.P. Berger, C. Gozzi, and H. Steiner Complication rate of transrectal ultrasound guided prostate biopsy: a comparison among 3 protocols with 6, 10 and 15 cores J Urol 171 2004 1478